These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8697065)

  • 1. Dehydroepiandrosterone and body fat.
    Clore JN
    Obes Res; 1995 Nov; 3 Suppl 4():613S-616S. PubMed ID: 8697065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity.
    Aoki K; Terauchi Y
    Vitam Horm; 2018; 108():355-365. PubMed ID: 30029734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiobesity effect of dehydroepiandrosterone in rats.
    Cleary MP
    Proc Soc Exp Biol Med; 1991 Jan; 196(1):8-16. PubMed ID: 1824576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.
    Nestler JE; Barlascini CO; Clore JN; Blackard WG
    J Clin Endocrinol Metab; 1988 Jan; 66(1):57-61. PubMed ID: 2961787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats.
    Kimura M; Tanaka S; Yamada Y; Kiuchi Y; Yamakawa T; Sekihara H
    Endocrinology; 1998 Jul; 139(7):3249-53. PubMed ID: 9645700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ; Haubrich RH; Hwang JY; Asakura H; Yen SS
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial.
    Villareal DT; Holloszy JO
    JAMA; 2004 Nov; 292(18):2243-8. PubMed ID: 15536111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism.
    Christiansen JJ; Gravholt CH; Fisker S; Møller N; Andersen M; Svenstrup B; Bennett P; Ivarsen P; Christiansen JS; Jørgensen JO
    Eur J Endocrinol; 2005 Jan; 152(1):77-85. PubMed ID: 15762190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and dehydroepiandrosterone/dehydroepiandrosterone sulfate relationships in lean, obese, and meat-type cross-bred boars: responses to porcine growth hormone.
    Wise T; Klindt J; Buonomo FC
    Endocrinology; 1995 Aug; 136(8):3310-7. PubMed ID: 7628365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity.
    Lemieux C; Picard F; Labrie F; Richard D; Deshaies Y
    Obes Res; 2003 Mar; 11(3):477-90. PubMed ID: 12634448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydroepiandrosterone sulfate levels in women. Relationships with body mass index, insulin and glucose levels.
    Al-Harithy RN
    Saudi Med J; 2003 Aug; 24(8):837-41. PubMed ID: 12939667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone supplementation is not beneficial in the late postmenopausal period in diet-induced obese rats.
    Teixeira CJ; Ribeiro LM; Veras K; da Cunha Araujo LC; Curi R; de Oliveira Carvalho CR
    Life Sci; 2018 Jun; 202():110-116. PubMed ID: 29601891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of dehydroepiandrosterone in obese men.
    Usiskin KS; Butterworth S; Clore JN; Arad Y; Ginsberg HN; Blackard WG; Nestler JE
    Int J Obes; 1990 May; 14(5):457-63. PubMed ID: 2143499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a long-term percutaneous adrenal steroid treatment on rat adipose tissue metabolism.
    Mauriège P; Langin D; Montminy V; Martel C; Després JP; Bélanger A; Labrie F; Deshaies Y
    Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S148-50. PubMed ID: 10997639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dehydroepiandrosterone sulphate, body fat distribution and insulin in obese men.
    Herranz L; Megia A; Grande C; González-Gancedo P; Pallardo F
    Int J Obes Relat Metab Disord; 1995 Jan; 19(1):57-60. PubMed ID: 7719392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
    Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dehydroepiandrosterone treatment in rats with diet-induced obesity.
    Mohan PF; Ihnen JS; Levin BE; Cleary MP
    J Nutr; 1990 Sep; 120(9):1103-14. PubMed ID: 2144587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone Research: Past, Current, and Future.
    Klinge CM; Clark BJ; Prough RA
    Vitam Horm; 2018; 108():1-28. PubMed ID: 30029723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women.
    Dhatariya K; Bigelow ML; Nair KS
    Diabetes; 2005 Mar; 54(3):765-9. PubMed ID: 15734854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic effects of dehydroepiandrosterone on rat adipose tissue metabolism.
    Mauriège P; Martel C; Langin D; Lacaille M; Després JP; Bélanger A; Labrie F; Deshaies Y
    Metabolism; 2003 Mar; 52(3):264-72. PubMed ID: 12647261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.